We are thrilled to announce that Dr. Panos Zanos, the Principal Investigator of the Translational Neuropharmacology Lab, has been appointed as a member of the Cyprus National Bioethics Committee (CNBC) following a rigorous application and interview process.

The CNBC plays a pivotal role in advising and guiding ethical practices in research, healthcare, and policy-making in Cyprus. Dr. Zanos’s expertise in neuropharmacology and his commitment to advancing ethical standards in neuroscience research will contribute to the committee’s mission of promoting responsible scientific progress.

For more information about the CNBC, visit https://www.bioethics.gov.cy.